Результатов: 11

Molecule Partners with VitaDAO and Nevermined Creating First-Ever Biopharma IP-to-NFT Transfer for Longevity Research

Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »

2021-8-18 16:00


Фото:

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovationRead More дальше »

2021-8-18 16:00


Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

Press Release: Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »

2021-8-18 16:00


Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer

Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfuThe post Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer appeared first on AMBCrypto. дальше »

2021-8-18 16:00


Фото:

Boosting a single brain molecule reduced anxiety in lab monkeys

Scientists may have found a potential cure for anxiety after isolating and boosting a molecule in the brains of rhesus monkeys. Andrew Fox, a researcher at UC Davis, and co-author Tade Souaiaia from SUNY lead a team of researchers in an experimental study to determine if behaviors related to anxiety and depression could be mitigated by manipulating the amygdala, the part of the brain that controls memory and emotions linked to memory. дальше »

2019-8-15 00:58